Drugs / FVT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06264219 Comparator | Aug 2024 → Aug 2027 expected | — | Jakob Stokholm | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FVT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06264219 ↗ |
| Action | Restore | “Another hypothesis is that seeding the virome fraction (FVT) will cause the neonate's microbiome to resemble the mother's” NCT06264219 ↗ |
| Modality | Other / unclassified | “Sterile-filtered and ultracentrifuged FMT, containing only viruses, is transferred from mother to infant.” NCT06264219 ↗ |